DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma-Reference-Cited by-同舟云学术

DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma

Published:2023-05 Issue: Volume:172 Page:82-91
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Arend Rebecca,Dholakia Jhalak,Castro Cesar,Matulonis Ursula,Hamilton Erika,Jackson Camille Gunderson,LyBarger Kristopher,Goodman Howard M.,Duska Linda R.,Mahdi Haider,ElNaggar Adam C.,Kagey Michael H.,Liu Amy,Piper Diane,Barroilhet Lisa M.,Bradley William,Sachdev Jasgit,Sirard Cynthia A.,O'Malley David M.,Birrer Michael

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference46 articles.

1. Integrated genomic characterization of adrenocortical carcinoma;Assie;Nat. Genet.,2014

2. QuPath: Open source software for digital pathology image analysis;Bankhead;Scientific reports,2017

3. Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer;Betella;Gynecol. Oncol.,2020

4. Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian Cancer;Betella;Gynecol. Oncol.,2020

5. p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cells;Browne;Cell Death Dis.,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Locally advanced and metastatic endometrial cancer: Current and emerging therapies;Cancer Treatment Reviews;2024-09

2. Dysfunction of dendritic cells in tumor microenvironment and immunotherapy;Cancer Communications;2024-07-25

3. Focusing on the Immune Cells: Recent Advances in Immunotherapy for Biliary Tract Cancer;Cancer Management and Research;2024-07

4. A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC);Prostate Cancer and Prostatic Diseases;2024-02-10

5. Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers;Journal for ImmunoTherapy of Cancer;2024-01